ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HSCS vs LFWD // EV/EBITDA & P/E VALUATION

HeartSciences Inc. (NASDAQ) VS. Lifeward Ltd. (NASDAQ) • 15-METRIC TALLY: HSCS 3 — LFWD 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSCS VS. LFWD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HSCS LFWD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 59.10% 96.00% -36.90 LFWD /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -0.70% -17.60% +16.90 HSCS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 LFWD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.7 44.8 +2.87 HSCS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $17.5M $16.7M $749.3K HSCS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HSCS REV LFWD REV HSCS GROSS % LFWD GROSS % HSCS FCF LFWD FCF
FY 2025 $4.3K $1.4M 59.1% 98.0% -$7.4M -$16.8M
FY 2024 $4.3K $1.7M 56.8% 98.0% -$7.4M -$21.7M
FY 2023 $18.6K $435.0K — — -$6.1M -$20.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSCS // BETA —
LFWD // BETA —